Data / Form D filings / Immuneering Corp
Immuneering Corp: Form D filings
Immuneering Corp, a biotechnology company in Cambridge, MA, filed 4 Form D notices with the SEC between 2019 and 2025. The latest, on September 9, 2025, reports $25 million sold of a $25 million offering to 9 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 245 MAIN STREET, SECOND FLOOR, Cambridge, MA, 02142
- Phone
- (617) 500-8080
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1790340
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 9, 2025 | New notice | $24,998,919 | $24,998,919 | 9 | Aug 26, 2025 | sec.gov | |
| Jan 5, 2021 | New notice | $61,999,582 | $37,199,807 | $24,799,775 | 39 | Dec 21, 2020 | sec.gov |
| Jan 27, 2020 | Amendment | $20,000,003 | $20,000,003 | 67 | Jan 6, 2020 | sec.gov | |
| Oct 4, 2019 | New notice | $14,973,755 | $14,973,755 | 49 | Sep 20, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Benjamin J. Zeskind | Executive Officer, Director | |
| Laurie B. Keating | Director | |
| Robert J. Carpenter | Director | |
| Thomas J. Schall | Director | |
| Diana F. Hausman | Director | |
| Peter J. Feinberg | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Sep 8, 2025 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Immuneering Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.